Linas S L, Miller P D, McDonald K M, Stables D P, Katz F, Weil R, Schrier R W
N Engl J Med. 1978 Jun 29;298(26):1440-4. doi: 10.1056/NEJM197806292982603.
To define the role of the renin-angiotensin system in post-transplantation hypertension we studied 12 hypertensive recipients of renal transplants. The patients received saralasin acetate, an angiotensin II antagonist, while on a normal sodium diet and again after seven days of sodium restriction. In six patients with only one kidney, saralasin did not lower blood pressure on either diet; salt depletion did not lower systolic or diastolic blood pressures. In six patients with more than one kidney, salt depletion also did not lower blood pressure; however, salt depletion plus saralasin lowered their systolic pressures from a mean (+/- S.E.M.) of 146 +/- 9 to 128 +/- 8 mm Hg, and mean diastolic pressures fell from 103 +/- 5 to 89 +/- 5 (P less than 0.001). In four of five patients renal-vein renin activity was greater in one or more host kidneys than in the transplant kidney (or kidneys). Although pre-transplant blood pressure was the same in both groups, post-transplantation hypertension is more likely to be angiotensin II-dependent in patients with more than one kidney.
为了明确肾素 - 血管紧张素系统在肾移植后高血压中的作用,我们研究了12例肾移植术后高血压患者。患者在正常钠饮食时以及限钠7天后接受了醋酸沙拉新(一种血管紧张素II拮抗剂)治疗。在6例仅有一个肾脏的患者中,无论何种饮食,沙拉新均未降低血压;限盐也未降低收缩压或舒张压。在6例有一个以上肾脏的患者中,限盐同样未降低血压;然而,限盐加沙拉新使他们的收缩压从平均(±标准误)146±9降至128±8 mmHg,平均舒张压从103±5降至89±5(P<0.001)。在5例患者中的4例,一个或多个宿主肾脏的肾静脉肾素活性高于移植肾。尽管两组患者移植前血压相同,但有一个以上肾脏的患者移植后高血压更可能依赖血管紧张素II。